Bio-Blog
Scaling Cell Therapies: Revolutionizing Healthcare for a Future of Cures and Hope
Cell therapies are heralding a transformative age in medicine, offering promising new avenues for treating a variety of debilitating diseases. As we...
Macrodevices for Cell Therapy II: Advances of Macrodevices
Macrodevices for Cell Therapies When discussing cell therapies, the term macroencapsulation indicates a device that is larger than 1 mm in...
Macrodevices for Cell Therapy I: Advantages and Disadvantages
On average, there are over 2600 clinical trials for cell and gene therapy products on any given day. Yet very few of these products have made it to...
Expanding Market Access to Cell Therapies: Plan Early to Scale Manufacturing Later
Cell and gene therapies are no longer a promise for the future. They are here today. In fields like oncology, pediatrics, and hematology, gene and...
Likarda Student Intern Recognized by BioNexus KC for ‘Graduate Student Best Poster Award and Scholarship’
Congratulations to our Kansas City University student intern, Kennedy Davis! She was recently awarded ‘Graduate Student Best Poster Award and...
Cell Therapies and Hydrogels: What is Crosslinking? | The Choice of a Hydrogel is Only Part of a Cell Therapy’s Success
Hydrogels start out as liquid solutions of individual polymer chains dissolved in an aqueous (water-based) solvent. To transform this liquid...
How Do Delivery Systems Impact Cell Therapy
As medical innovations advance, cells can be used to repair sites of injury or reverse the effects of disease. However, one of the major challenges...
The “Myth” of Homing: Why Do Cells Need A Delivery System?
It is often thought that therapeutic cells make their way from the point of injection to the location they’re needed. However, this is highly...
What is Biocompatibility and Why Does It Matter?
Medical devices have been implanted in human bodies for decades, starting with the first pacemaker implanted in 1958. In fact, it is estimated that...
2022 NULA and Dr. Julius Wayne Dudley Awards Presented to Dr. Francis Karanu
Dr. Francis Karanu, Likarda’s Director of Cell Therapy and Research and Development was named the 2022 recipient of the Newton Universal Legendary...
Search
Categories
Improving Osteoarthritis Care with Likarda Core Shell Spherification Microbeads
Likarda’s scientists recently published a paper in the journal, Bioengineeing, that demonstrates...
Likarda and Evia Bio Announce Novel Tech Cryo Partnership
Kansas City, MO, October 10, 2023 – Likarda, a leader in cell therapy encapsulation for delivery...
Likarda Announces Core Shell Spherification for Large Molecule Biologics and Welcomes New CEO, Dr. Stella Vnook
Cambridge, Massachusetts, September 13, 2023 – Likarda, LLC, a pioneering cell therapy company, is...
Don't miss out on new resources!
Get our monthly newsletter